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Received August 12, 2015; accepted June 24, 2016AbstractBackground: The etiology of autism is complex, and may involve the interaction between genetic and environmental factors. Recent studies
suggested an association between maternal immune response and this disorder.
Methods: Forty-nine women with autistic children (cases) were studied in comparison with 73 women with normal children (controls). After
interviewing for sociodemographic and clinical information, mothers' sera were tested for the presence of antineuronal antibodies.
Results: Mothers of autistic children had significantly higher seropositivity for anti-Yo antibodies (34.7%) than control women (13.7%), with an
(adjusted odds ratio of 2.60 (95% confidence interval, 1.03e6.61; p¼ 0.044). Similarly, women with autistic children showed significantly
higher seropositivity for antiamphiphysin than the control group (40.8% vs. 17.8%), with an adjusted odds ratio of 2.54 (95% confidence in-
terval, 1.07e6.04; p¼ 0.035). No significant association was found between autism spectrum disorders and maternal anti-Hu antibodies and
anti-Ri antibodies, and the history of autoimmune diseases.
Conclusion: Some maternal antineuronal antibodies may contribute significantly to the risk of childhood autism.
Copyright © 2016, the Chinese Medical Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Autism spectrum disorders (ASDs) manifest as highly
variable combined deficits in social interaction, and verbal and
nonverbal communication, and often include the presence of
repetitive, stereotypical, and overly restrictive behaviors.1 The
prevalence has increased substantially over the last decade to
approximately 1 in 100 children.2 The causes of ASDs are
unknown, but there is an emerging consensus that ASDs haveConflicts of interest: The authors declare that they have no conflicts of interest
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).multiple etiologies, although genetic, neurologic, environ-
mental, and immune factors are likely involved.3 The symp-
toms of ASDs are usually diagnosed in early childhood,
supporting the current view of a prenatal or early postnatal
etiology.4 Autism develops before the 36th month of age and
persists into adulthood, causing lifelong disability.5
One proposed cause of ASDs is exposure of the fetal brain
to maternal autoantibodies during pregnancy.6 An etiologic
role of maternal antibodies in ASDs is plausible due to the
dynamics of the gestational transfer of maternal immuno-
globulin G (IgG) during pregnancy. In humans, maternal
antibodies are detected in fetal circulation as early as 13
weeks of gestation, and their concentration increases to
approximately 50% of maternal levels by 30 weeks of
gestation.7 Many neonatal cases of diseases associated with
antibody-mediated autoimmune diseases in the mother aresevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
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suffer from hypothyroidism as a result of maternal antithyroid
peroxidase. A mother with systemic lupus erythematous
transfers N-methyl-D-aspartic acid receptor autoantibodies to
the fetus during pregnancy, causing death of fetal neurons and
hence resulting in congenital brain injuries.9
Bauman et al10 reported that the reactivity of maternal
antibodies to fetal brain proteins at 37 kDa and 73 kDa is
associated with ASDs and certain childhood behavioral dis-
orders. Those researchers then examined whether maternal
antibodies related to autism would induce behavioral changes
in rhesus monkeys. Three groups of pregnant rhesus monkeys
were included in the study: the first group received purified
IgG from mothers of children with autism, the second group
received purified IgG from mothers of typically developing
children, and the third group included untreated controls.
Monkeys born to mothers administered with autism maternal
serum showed increased whole-body stereotypes across mul-
tiple testing paradigms. These monkeys were also hyperactive,
while monkeys born to mothers treated with IgG from mothers
of normally developing children and untreated monkeys did
not show any significant changes in stereotypes.
Various antibrain antibodies have been found in autistic
patients, including autoantibodies to serotonin receptors,11
neuron axon filament protein,12 myelin basic protein,13 cere-
bellar neurofilaments,14 nerve growth factor,15 and alpha-2-
adrenergic binding sites.16
Although paraneoplastic antineuronal antibodies have an
association with particular tumors, most commonly small cell
lung, breast, and ovarian tumors, they are also detected in
patients with neurological syndromes of unknown etiology
and occasionally in healthy individuals.17 Several categories of
paraneoplastic antineuronal antibody targets exist. They target
either nuclear or cytoplasmic protein antigens such as anti-Yo
and anti-Hu, or intracellular synaptic proteins such as
antiamphiphysin.18
Antineuronal antibodies have been suggested to play a
central role in the pathogenesis of neuropsychiatric disor-
ders.19,20 These disorders can occur in patients with or without
cancerdoften children or young adults.18
Since autism may be one of the pediatric autoimmune
neuropsychiatric disorders, this study was conducted to
investigate the expression of maternal antineuronal antibodies,
as an index of autoimmunity to brain, in autistic children
2. Methods
This caseecontrol study was conducted in the Autism
Center, the only private center for autism in Basrah, for the
period from August 2014 to November 2014.
Cases were mothers of at least one child with confirmed
diagnosis of ASD by pediatric specialists based on the Autism
Diagnostic Observation Schedule21 and the Autism Diagnostic
IntervieweRevised.22 Controls were apparently healthy
women with normally developing children. Controls were
randomly selected from women who were attending a primary
health care center. Both groups were without a history ofassistant reproductive technique for their childbirth and had no
drug intake history. Both groups were frequency matched for
age. Data were collected using a questionnaire covering the
age of the mothers and children, sex of the child, and the
history of autoimmune diseases among mothers during or
before pregnancy.
Immunoblotting tests (Ravo Diagnostika, Freiburg, Ger-
many) were used for the detection of anti-Hu, anti-Ri, anti-Yo,
and antiamphiphysin autoantibodies in mothers' serum. Ac-
cording to manufacturer's instructions,23 serum samples were
diluted 1:2000 in ready-to-use sample dilution buffer. Strips
with 2 mL of the diluted serum specimen were incubated for
60 minutes at room temperature on a rocking table. All strips
were washed five times with diluted wash buffer, and then
2 mL alkaline phosphatase IgG conjugate, ready to use, per
strip was added. Each strip in 2 mL ready-to-use substrate
solution was incubated for 25 minutes at room temperature
until the bands became clearly visible. The strips were trans-
ferred to distilled water to stop the reaction. Then the strips
were placed onto a filter paper for drying and stored the in the
dark. Finally, the strips were compared by control scan.
This study was approved by the Ethics and Research
Committee of College of Medicine, Basrah University. Writ-
ten consent was obtained from each mother before being
enrolled in the study.2.1. Statistical analysisThe data were analyzed using Statistical Package for the
Social Sciences, version 20 (IBM Corp., Chicago, Illinois,
USA). Frequencies and percentages were calculated for cate-
gorical variables, and chi-square (c2) test was used for
assessing the association between these variables. Means and
standard deviations (SDs) were measured for quantitative data.
Multivariate logistic regression analysis was used to identify
the independent risk factors of ASDs. A p value of <0.05 was
considered to be statistically significant.
3. Results
The number of mothers with autistic children was 49
(cases), their mean age and SD was 30.0± 6.8 years, and the
age range of their children was 5e16 years with a mean and
SD of 9.9± 2.0. The number of mothers with normal children
was 73 (controls). Their mean age and SD was 29.6± 6.6, and
the age range of their children (normal) was 5e16 years, with
mean of 10.0± 2.1. Boys constituted 63.3% of autistic chil-
dren, with no significant association between sex and autism
(Table 1). Autoimmune diseases (including celiac disease,
rheumatoid arthritis, thyroiditis, antiphospholipid syndrome,
autoimmune hemolytic anemia, and rheumatic fever) were
found in 53.1% of the mothers of autistic children and 60.3%
of the mothers of normal children, without significant asso-
ciation ( p¼ 0.546).
In univariate analysis, anti-Hu and anti-Ri antineuronal
autoantibodies were detected, respectively, in the sera of
32.7% and 32.7% of the mothers of autistic children compared
Table 1
Association of antineuronal autoantibodies and certain risk factors with autism
spectrum disorders.
Cases
No. (%)
Control
No. (%)
c2, p OR (95% CI)
Gender 0.79 (0.37e1.69)
Boys 31 (63.3) 50 (68.5) 0.359, 0.549
Girls 18 (36.7) 23 (31.5)
Anti-Hu Ab 1.59 (0.71e3.58)
Positive 16 (32.7) 17 (23.3) 1.303, 0.254
Negative 33 (67.3) 56 (76.7)
Anti-Ri 1.88 (0.82e4.27)
Positive 16 (32.7) 15 (20.5) 2.267, 0.132
Negative 33 (67.3) 58 (79.5)
Anti-Yo Ab 3.35 (1.38e8.15)
Positive 17 (34.7) 10 (13.7) 7.500, 0.006
Negative 32 (65.3) 63 (86.3)
Antiamphiphysin 3.18 (1.47e7.91)
Positive 20 (40.8) 13 (17.8) 7.866, 0.005
Negative 29 (59.2) 60 (82.2)
Maternal autoimmune disease 1.34 (0.67e2.76)
Positive 26 (53.1) 44 (60.3) 0.624, 0.546
Negative 23 (46.9) 29 (39.7)
Ab¼ antibody; CI¼ confidence interval; OR¼ odds ratio.
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dren, with no significant association. However, anti-Yo and
antiamphiphysin antibodies were positive, respectively, in the
sera of 34.7% and 40.8% of the mothers of autistic children
(cases) compared with 13.7% and 17.8% of the controls
(mothers without autistic children), with a highly significant
association.
The association of anti-Yo and antiamphiphysin with ASDs
remained strongly positive after multivariate logistic regres-
sion analysis, as shown in Table 2.
4. Discussion
In this analytical study, we assessed the hypothesis that
there is an association between maternal neuronal antibodies
and childhood ASDs.
This study showed that some of these autoantibodies, anti-
Yo and antiamphiphysin, existed significantly more in the sera
of mothers with an autistic child than in the sera of mothers of
normally developing children. Anti-Hu and anti-Ri were more
prevalent in mothers of autistic children than in control
mothers, but without a significant association. This result
emphasizes the heterogeneity that encompasses autism and the
diversity of causative theories that exist.24 Dalton et al,6 in
their study on mice, proposed a role for maternal antibodies in
the etiology of neurodevelopmental disorders, but notTable 2
Logistic regression analysis.
Variable В-coefficient p OR 95% CI
Lower Upper
Anti-Yo 0.957 0.044 2.60 1.03 6.61
Antiamphiphysin 0.933 0.035 2.54 1.07 6.04
CI¼ confidence interval; OR¼ odds ratio.necessarily that they are responsible for all cases of autism or
other neurodevelopmental disorders.
The results of our study are in line with those reported by
Passarelli et al,25 who found a significant positive response to
the anti-Yo antibody immunoreactivity in the Purkinje cells of
the cerebellum of children with attention deficit hyperactivity
disorder (ADHD). Other investigators have identified the
presence of antibodies that bind to the brain in mothers with
ASD offspring.26,27
Zimmerman et al28 found that specific patterns of antibody
reactivity were present in the sera of mothers of autistic
children, from 2 years to 18 years after the birth of their
affected children, and were unrelated to birth order; they
suggested that these autoantibodies could cross the placenta
and alter fetal brain development.
Bauman et al10 and Martin et al29 examined the morbific
potency of these autoantibodies by administrating IgG isolated
from the sera of mothers of autistic children to female rhesus
monkeys during early and midpregnancy, and then assessed
the behavioral and brain development of the offspring. They
found alteration in the brain growth, deviation from normal
social behavior, and abnormality of growth of the brain. Fox
et al30 reported that maternal antibodies to fetal brain had been
identified as one exposure during fetal life that may put a child
at risk for ASDs.
Piras et al,31 in their study on autistic children, found that the
presence of patient- and mother-produced antibrain antibodies
did not confer an increased risk of autism within the same sib-
ship. However, maternal antibrain antibodies were associated
with neurodevelopmental delay in their autistic children.
Maternal antibodies may have a direct antigeneantibody
interaction resulting in functional interference of the target
proteins, or the presence of these antibodies may be merely a
biomarker of cell destruction.32
Our study found no significant association between the
presence of maternal autoimmune diseases and ASDs, a result
also reported by Croen et al33 who suggested that maternal
autoimmune disorders present in women around the time of
pregnancy are unlikely to contribute significantly to autism
risk. Another study also did not find an association between
ulcerative colitis and ASDs.34 However, a Swedish study35
revealed that many maternal autoimmune diseases were
associated with autism, including Type 1 diabetes mellitus,
idiopathic thrombocytopenic purpura, myasthenia gravis, and
rheumatic fever.
There are some reasonable and valid ways to explain the
effect of the disturbance of maternal immune system on ASDs;
it can be through determination of the growth of the brain by
initiation of unfavorable surrounding in the uterine cavity,6,29
or by changing the immunity of the child by the cross of
IgG through the placenta, which leads to either temporary or
long-lasting structural harm to the child.36
One limitation of this study is that we were able to measure
autoantibodies in maternal serum only at one point after
pregnancy, so it is difficult to prove whether the antibodies that
we measured were present earlier or later after pregnancy. This
limitation does not rule out the possibility that some of these
664 N.H. Ali et al. / Journal of the Chinese Medical Association 79 (2016) 661e664maternal autoantibodies had a role in autism, since abnor-
malities in brain development may not be detected until
months to years after birth.37 In addition, an age-dependent
decline in antibody levels is not commonly observed in
autoimmune disorders.38 Furthermore, adult ADHD is defined
as ADHD that appeared before the age of 12 years and persists
beyond 17 years of age.39 At that time, the possible causes of
brain damage are many. A prospective cohort study of sub-
sequent offspring born to mothers with positive serum para-
neoplastic antibodies who already have one child, with or
without ASD, will resolve this issue.
In conclusion, the results of this study, along with those of
previous studies, support the potential use of mother anti-
neuronal antibodies as biomarkers to predict the risk of ASDs,
which may provide new ways to prevent and treat autism.
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